30
POLYMERS IN SOLID STATE AND PHARMACEUTICAL APPLICATIONS OF POLYMERS BY M. PRIYANKA M. PHARMACY SCHOOL OF PHARMACEUTICAL SCIENCES AND TECHNOLOGIES, JNTUK

POLYMERS IN SOLID STATE, PHARMACEUTICAL APPLICATIONS OF POLYMERS AND RECENT ADVANCES IN THE USE OF POLYMERS FOR DRUG DELIVERY SYSTEM

Embed Size (px)

Citation preview

POLYMERS IN SOLID STATE AND

PHARMACEUTICAL APPLICATIONS OF POLYMERS

BY

M. PRIYANKA

M. PHARMACY

SCHOOL OF PHARMACEUTICAL SCIENCES AND TECHNOLOGIES, JNTUK

CONTENTS

POLYMERS IN SOLID STATE

• Solid state properties

• Mechanical properties

• Thermodynamics of fusion & crystallization

• Heat of crystallization & fusion

PHARMACEUTICAL APPLICATIONS OF POLYMERS

• Applications of polymers in formulation of controlled drug delivery system

• Other applications

• Recent advances in the use of polymers for drug delivery systems

[email protected]

2

POLYMERS IN SOLID STATE

• The use of solid polymers depends on their mechanical, permeability, thermal &

optical properties which are governed by their chemical nature & morphological

characteristics.

A. SOLID STATE PROPERTIES:

a) THE AMORPHOUS STATE:

Randomly coiled interpenetrating chains

Not all volume is occupied: free volume concept

Diffusion of small molecules

Segmental & chain mobility strongly dependent on temperature & free volume

Entanglements at sufficiently high molecular [email protected]

3

b) SEMI-CRYSTALLINE STATE:

Partly ordered & partly folded state

c) CRYSTALLINE STATE:

Stiffness & brittleness

Fracture strength & elongation at break

Solubility

Permeation of gases & water sorption

[email protected] 4

B. MECHANICAL PROPERTIES:

Solids can be deformed by tension, bending, shear, torsion & compression. The

most widely used tool is tension. The following discussion is limited to tension.

Stress is the applied force F, per unit area of cross section A. stress in tension is

called tensile stress . The mostly used units of stress are lb/𝑖𝑛2 or psi, dyne/cm2. The

effect of stress is deformation or strain. Strain intension is called elongation∈. It is the

increase in length ∆𝐿 = 𝐿 − 𝐿𝜊 relative to the original length L0

∈=𝐿 − 𝐿0𝐿0

= ∆𝐿/𝐿0

[email protected]

5

• L is the length under a given tensile stress. Ideal or elastic solids are deformed

when subjected to stress. But regain their original shape & dimension when the

stress is released. According to Hooke’s law, the stress is directly proportional to

the strain.

𝐹

𝐴=𝐸 𝐿 − 𝐿𝜊

𝐿𝜊

• The proportionally constant E called Young’s modules or modules of elasticity is a

measure of hardness, stiffness or rigidity of a solid.

𝐸 = Δ𝜎/Δ ∈

[email protected] 6

a) INTER CHAIN COHESIVE FORCES :

The forces responsible for the mechanical strength of packaging films & plastic

containers are the secondary valence forces between adjacent polymer chains.

The most commercial films, fibres, plastics & elastomers are all in the range

of 70-85 K.cal/mole. Cohesive energies b/w 1.0 & 2.0K.cal/mole are the lowest.

The solid polymers of this category are elastomers with the lowest mechanical

strength plastics are stronger. Their cohesive energies range from 2-5 K.cal/mole &

involve dipole-dipole attraction in addition to dispersion forces. The highest inter

chain attraction greater than 5 K.cal/mole produces materials with the highest

strength, suitable for use as films & fibers.

[email protected] 7

b) CRYSTALLINITY:

• Maximum inter chain attraction resulting in greatest mechanical strength; Thus, to

be mechanically strong, A polymer should highly crystalline. Conversely, a weaker

& soften polymer for use as elastomer can be obtained by preventing

crystallization by random co-polymerization. Short chain branching disrupts the

crystallinity of solid polymers & weakens them mechanically.

[email protected] 8

c) MORPHOLOGY

• Crystalline domains are called crystallites. They alternate with more disordered

amorphous regions. Single polymer chain often run through several contiguous

crystallites & amorphous regions. Crystallization proceeds as these nuclei grow

into crystallites until all the solvent has evaporated or all the malt has solidified.

[email protected] 9

d) SPHERULITES:

• Crystallization in synthetic polymers often produces polycrystalline aggregates

called spherulites. These are spherical, radially symmetric arrays of fibrillary

crystallites ranging in diameter from less than 1 to several mm.

• Slow cooling of molten plastics produces fewer but large spherulites. The addition

of nucleating agents produces more & small spherulites.

[email protected] 10

C. THERMODYNAMICS OF FUSION & CRYSTALLIZATION:

• A binary system solvent-polymer is now applied to the one component system

consisting of the polymer aloe, to describe the reversible process.

Liquid amorphous polymer

Solid crystalline polymer

Solidification &

Crystallization

Melting or

Fusion

Gf = Hf - [email protected] 11

D. HEAT OF CRYSTALLIZATION & FUSION:

• The latent heat of crystallization or solidification HCR is negative because the

process is exothermic. When the polymer is solid, the chains arrange themselves

into an orderly lattice heat of fusion HF represents the energy that must be

supplied to break large fraction of the secondary valence forces between

neighbouring chains as the polymer melts. High density poly ethylene has a heat

of crystallization of -1850 cal/mole & heat of fusion of +1850 cal/mole. The

corresponding values for low density polyethylene are about one half of these

because of its lower crystallinity.

[email protected] 12

E. ANALYTICAL TECHNIQUES FOR POLYMER ANALYSIS:

Electron microscopy

Gel permeation chromatography with multiple detection

NMR (nuclear magnetic resonance)

Pyrolysis GC

Thermal analysis, TGA & DSC

X-ray diffraction techniques

[email protected] 13

PHARMACEUTICAL APPLICATIONS OF POLYMERS

• Polymers plays an important role in pharmaceuticals. In the 20th revision of the US

pharmacopoeia, polymers have officially entered into the world of pharmacy. As

the polymers have different kind of applications, they have been using in various

dosage forms as

Binders

Suspending agents

Emulsifying agents

Drug release modifiers

Disintegrating agents

Coating materials

[email protected]

14

A. APPLICATIONS OF POLYMERS IN FORMULATION OF CONTROLLED DRUG DELIVERY SYSTEM

• Oral drug delivery system

• Transdermal drug delivery system

• Ocular drug delivery system

[email protected] 15

1. ORAL DRUG DELIVERY SYSTEM:

Here, the drug gets released at controlled rate when administered orally. For that

several mechanisms are involved.

a) Osmotic pressure controlled GI delivery system

b) Gel diffusion controlled GI delivery system

c) Muco-adhesive GI delivery system

[email protected] 16

a) OSMOTIC PRESSURE CONTROLLED GI DELIVERY SYSTEM:

It is a controlled release oral drug delivery system in the form of a tablet. The

tablet has a rigid water permeable jacket. As the tablet posses through the body,

the osmotic pressure of water entering the tablet pushes the active drug through

semi-permeable membrane. In this system, semi-permeable membrane plays a key

role. Release of drug depends on it. Semi-permeable membrane is made from

biocompatible polymers.

E.g. Cellulose acetate

[email protected] 17

b) GEL DIFFUSION CONTROLLED DELIVERY SYSTEM:

The main feature of this system is that the drug core is enclosed with a partially

soluble membrane.

E.g. Carboxy methyl cellulose

c) MUCOADHESIVE DRUG DELIVERY SYSTEM:

It interacts with the mucus layer covering the mucosal epithelial surface, mucin

molecules & increase the residence time of the dosage form at the site of

absorption. In this, a polymer is required to produce an adhesion interaction with a

biological membrane.

E.g. carbopol

[email protected]

18

2. TRANSDERMAL DRUG DELIVERY SYSTEM:

TDDS is defined as self contained, self discrete dosage forms, which when applied

to the intact skin delivers the drug at a controlled rate to the systemic circulation. In

this, polymer matrix plays a major role. It releases the drug from the device to the

skin.

E.g. Natural polymers

Cellulose derivative, gelatin, shellac, waxes, gums

Synthetic polymers

Polyvinyl chloride, polyethylene, polyvinyl pyrrolidone

[email protected] 19

3. OCULAR DRUG DELIVERY SYSTEM:

It allows prolonged contact of drug with corneal surface of eye. The example

for ODDS is pilocarpine in the treatment of glaucoma.

In this mucoadhesive polymers are used as barriers to control the drug

release.

E.g. Polyacrylic acid

Copolymers of acetate vinyl & ethyl

[email protected] 20

B. OTHER APPLICATIONS

1) DRUG DELIVERY OF VARIOUS CONTRACEPTIVES & HORMONES:

E.g. medroxyprogesterone acetate – vaginal contraceptive ring

It consists of a drug reservoir & polymer coating material. Through this layer the

drug releases slowly.

2) DRUG DELIVERY AND HE TREATMENT OF DIABETES

Here the polymer will act as barrier between blood stream & insulin

E.g. polyacrylamide or N,N-dimethylaminoethylmethacrylate

[email protected] 21

3) APPLICATIONS OF POLYMERS IN SOLID DOSAGE FORMS:

IN TABLETS

Polymers like methyl cellulose, hydroxyl ethyl cellulose, hydroxyl ethyl

methylcellulose are used as binders.

Polymers like carboxyl methyl cellulose sodium is used as disintegrating agent.

Polymers like all the cellulose derivative are used as coating materials.

Polymers like cellulose acetate phthalate, hydroxyl propyl methyl cellulose

phthalate, polyvinyl acetate phthalate are used as enteric coating material

IN CAPSULES

Gelatin, a natural polymer which is the major ingredient in the manufacturing of

[email protected]

22

4) APPLICATIONS OF POLYMERS IN LIQUID DOSAGE FORMS:

IN SUSPENSIONS

Polymers like Acacia, Tragacanth, Cellulose derivative, Xanthum gum are used as

suspending agents. They should be selected based on their characters like PH,

solubility & concentration. They enhances the dispersion of solids in liquids.

IN EMULSIONS

Polymers like Tragacanth, Spans, Tweens are used as emulsifying agents.

[email protected]

23

5) Polymers can be used as film coatings to mask the unpleasant taste of a drug &

to modify drug release characteristics.

6) Polyanhydrides are used in CDDS because of their unique property of surface

erosion.

7) Hyaluronic acid is used in controlled release ophthalmic preparations.

8) Wide variety of polymers like natural gums are using as thickening agents.

E.g. polyethylene glycol, carbomer

9) Some of the polymers are using as protective colloids to stabilize suspensions &

emulsions. E.g. sodium alginate

10)Some polymers can be used as suppository bases E.g. polyethylene [email protected] 24

11)Some polymers are used in uterus therapeutic system E.g. silicone

12)Copolymers of lactide & glycolide, silicone are using in implantation therapeutic

system.

13)Polyurethanes can be used for elasticity

14)Polymethyl methacrylate for physical strength & transparency.

15)Polyvinyl alcohol for hydrophilicity & strength

16) In addition to polymers being used as excipients, some drugs themselves are

polymers including insulin, heparin & its antagonist, protamine sulfate, plasma

expander like dextran, normal human serum albumin, bulk laxatives like methyl

cellulose & sodium carboxy methyl cellulose.

[email protected]

25

Thus, polymers are essential to the

Dispensing pharmacist

Manufacturing pharmacist

Research pharmacist

[email protected] 26

RECENT DEVELOPMENTS IN USE OF POLYMERS FOR DRUG DELIVERY SYSTEMS

• Some researchers have prepared collagen poly-HEMA (polyhydroxyethylmethacrylate)

hydrogels as an implant for delivering anti cancer drugs such as 5-fluoro uracil,

mitomycin & bleomycin for solid fibro sarcoma in rat model.

• The same hydrogels have been used with some modifications for the delivery of model

protein bovine serum albumin& vaccines such as Tetanus & Diphtheria toxoids in mice.

[email protected] 27

• The recent technique in the use of polymers is polymeric pro-drug

The polymeric prodrug can be regarded as drug delivery system that

exhibit their therapeutic activity by means of releasing smaller therapeutic

drug molecules from a polymer chain molecule for a prolonged period of

time which results in enhanced pharmacokinetic behaviour by increasing the

t1/2, bioavailability & hence prolonged pharmacological action.

E.g. Anti cancer drugs

[email protected] 28

REFERENCE

• www.globalresearchonline.net

• Pharmaceutical applications of polymers for drug delivery by D. Jones

• www.wikipedia.com

• www.google.co.in

[email protected] 29

Priyanka Modugu